
Opi Pharma Private Limited
This company manufactures and trades pharmaceutical, surgical, and healthcare products, including ayurvedic preparations and cosmetics.
This company manufactures and trades pharmaceutical, surgical, and healthcare products, including ayurvedic preparations and cosmetics.
Opi Pharma Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 April 2021 (Four years 0 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.05 Cr.
The company currently has active open charges totaling ₹46.00 Cr. The company has closed loans amounting to ₹29.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Goyal, Ranjna Goyal, Abhishek Singla, and Four other members serve as directors at the Company.
Panchkula, Haryana, India
+91-XXXXXXXXXX
U24230HR2021PTC094384
094384
Private Limited Indian Non-Government Company
12 Apr 2021
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rakesh Goyal ![]() | Director | 12-Apr-2021 | Current |
Ranjna Goyal ![]() | Director | 12-Apr-2021 | Current |
Abhishek Singla ![]() | Director | 30-Dec-2023 | Current |
Rayma Singla ![]() | Director | 30-Dec-2023 | Current |
Rakshit Goyal ![]() | Additional Director | 06-Apr-2023 | Current |
Pankaj Jain ![]() | Additional Director | 13-Apr-2023 | Current |
Opi Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Opi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Rakesh Goyal, Ranjna Goyal and 3 more are mutual person
Rakesh Goyal, Ranjna Goyal and 3 more are mutual person
Rakesh Goyal, Ranjna Goyal and 1 more are mutual person
Rakesh Goyal, Ranjna Goyal and 1 more are mutual person
Rakesh Goyal, Ranjna Goyal and 1 more are mutual person
Rakesh Goyal, Ranjna Goyal and 1 more are mutual person
₹46.00 Cr
₹29.50 Cr
Date | Lender | Amount | Status |
---|---|---|---|
12 Sep 2023 | Others | ₹43.50 Cr | Open |
12 Sep 2023 | Others | ₹2.50 Cr | Open |
25 Apr 2023 | Others | ₹2.50 Cr | Satisfied |
25 Apr 2023 | Others | ₹27.00 Cr | Satisfied |
Opi Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Opi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Opi Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Opi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Opi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Abhishek Singla was appointed as a Director was appointed as a Director on 30 Dec 2023 & has been associated with this company since 1 year 3 months .
Rayma Singla was appointed as a Director was appointed as a Director on 30 Dec 2023 & has been associated with this company since 1 year 3 months .
A charge with Others amounted to Rs. 43.50 Cr with Charge ID 100785700 was registered on 12 Sep 2023.
A charge with Others amounted to Rs. 2.50 Cr with Charge ID 100785708 was registered on 12 Sep 2023.
Opi Pharma Private Limited was incorporated on 12 Apr 2021.
The authorized share capital of Opi Pharma Private Limited is ₹ 8.00 Cr and paid-up capital is ₹ 6.05 Cr.
Currently 7 directors are associated with Opi Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Opi Pharma Private Limited is Sco 261 Sector-14 Urban Estate, India, Panchkula, Haryana, 134109.
The corporate identification number (CIN) of Opi Pharma Private Limited is U24230HR2021PTC094384 and the company number is 094384 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 2023, The total open charges for Opi Pharma Private Limited amount to ₹ 46.00 Cr.
The most recent Balance Sheet for Opi Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.